UK markets closed

Compass Therapeutics, Inc. (CMPX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
5.45+0.25 (+4.81%)
At close: 3:44PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5279.66M
Enterprise value 3239.51M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-8.80

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-35.88%
S&P500 52-week change 338.24%
52-week high 311.00
52-week low 33.53
50-day moving average 35.41
200-day moving average 36.28

Share statistics

Avg vol (3-month) 35.52k
Avg vol (10-day) 315.39k
Shares outstanding 551.31M
Implied shares outstanding 6N/A
Float 20.54M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-52.00%
Return on equity (ttm)-158.20%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -27.22M
Net income avi to common (ttm)-30.52M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)39.7M
Total cash per share (mrq)0.77
Total debt (mrq)12.38M
Total debt/equity (mrq)36.97
Current ratio (mrq)3.84
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-24.65M
Levered free cash flow (ttm)-12.06M